Methylprednisolone Acetate Injectable Suspension — Class III drug recall D-0756-2023
Terminated recall by Amneal Pharmaceuticals of New York, LLC, reported 2023-05-31, distributed nationwide. Labeling: Not Elsewhere Classified; A typographical error was observed in the NDC number on the preprinted Ind
| Recall number | D-0756-2023 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Amneal Pharmaceuticals of New York, LLC, Brookhaven, NY, United States |
| Recall initiated | 2023-05-08 |
| Classified | 2023-05-19 |
| Reported by FDA | 2023-05-31 |
| Terminated | 2024-03-21 |
| Distributed | Nationwide (US) |
| Quantity | 69,239 vials |
| Reason classes | labeling |
| NDC | 70121-1574-01 |
| Lot numbers | AP220481, AP220536A |
| Expiration dates | 2024-09, 2024-10 |
Product
Methylprednisolone Acetate Injectable Suspension, USP 80 mg/mL, For Intramuscular, Intrasynovial and Soft Tissue Injection Only, Not for Intravenous Use, 1 mL Single Dose Vial, Manufactured by: Amneal Pharmaceuticals Pvt. Ltd. Parenteral Unit, Ahmedabad 382213, India, Amneal Pharamceuticals LLC, Bridgewater, NJ 08807, NDC 70121-1574-01.
Reason for recall
Labeling: Not Elsewhere Classified; A typographical error was observed in the NDC number on the preprinted Individual Folding Cartons (secondary packaging only). Incorrect NDC Number 70121-1573-1; Correct NDC Number 70121-1574-1.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0756-2023. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.